{"filings":[{"id":555326,"accession_number":"0001213900-26-059557","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-05-20T20:30:21+00:00","items":["5.02","9.01"],"status":"ready","headline":"Modular Medical grants 15,892 stock options to CEO/CFO and COO","event_type":"other_material","confidence":"high","bullets":["11,218 options awarded to Chairman/President/CFO Paul DiPerna.","4,674 options awarded to COO Kevin Schmid.","Exercise price $3.46; vesting begins May 14, 2027 (1/3) then monthly (1/24).","Options expire on May 14, 2036; granted under Amended 2017 Equity Plan.","No departure or election; purely compensatory arrangement for named officers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91111,"accession_number":"0001213900-26-045985","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Modular Medical prices $3.4M offering of 750k shares at $4.50 each","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$3.4M from sale of 750,000 shares; closing expected April 21, 2026.","Offering priced at $4.50 per share under effective shelf registration S-3 (333-287313).","Maxim Group LLC is sole placement agent with a 7% fee and up to $75k expense reimbursement.","Directors and officers subject to 90-day lock-up; company restricted from new issuances for 45 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91110,"accession_number":"0001213900-26-044343","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-04-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Modular Medical regains Nasdaq minimum bid price compliance as of April 14, 2026","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq letter on April 15, 2026 confirming compliance with $1.00 minimum bid price requirement.","Closing bid price exceeded $1.00 for 10 consecutive trading days through April 14, 2026.","Nasdaq considers the matter closed; no further action required.","MODD common stock continues trading on the Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101032,"accession_number":"0001213900-26-037531","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"Modular Medical announces 1-for-30 reverse stock split to regain Nasdaq compliance","event_type":"other_material","confidence":"high","bullets":["Reverse split effective 5:30am ET March 31, 2026; trading on split-adjusted basis under MODD symbol.","Ratio: 1-for-30; outstanding shares reduced from 139,810,797 to approximately 4,660,360.","Purpose: increase per-share price to satisfy $1.00 minimum bid price for continued Nasdaq listing.","Authorized shares and par value unchanged; fractional shares paid in cash.","All equity awards and warrants adjusted proportionally (exercise price multiplied by 30)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101031,"accession_number":"0001213900-26-027652","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-03-13T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Modular Medical lays off 29% of workforce to cut annual costs by $3.4M","event_type":"other_material","confidence":"high","bullets":["Layoff of 20 positions, representing ~29% of total workforce, effective March 12, 2026.","Expected annual operating expense reduction of approximately $3.4 million.","Non-recurring charges estimated at $0.1M–$0.2M, mainly severance; majority by June 30, 2026.","Company prioritizing higher-ROI projects to reduce cash burn."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101030,"accession_number":"0001213900-26-024671","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-03-06T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Modular Medical raises $12M via public offering of 68M shares and warrants","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$12M from sale of 68,098,000 shares (or pre-funded warrants) and 68,098,000 warrants at $0.1762/unit.","Warrants exercisable immediately at $0.1762, expire in five years.","Maxim Group LLC acted as sole placement agent; lock-up agreements for directors/officers for 90 days.","Offering closed March 4, 2026; proceeds for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101029,"accession_number":"0001213900-26-019603","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["1.01","9.01","2.03"],"status":"ready","headline":"Modular Medical secures $350K revolving credit facility from CEO; 12% interest, secured by all assets","event_type":"debt","confidence":"high","bullets":["$350,000 revolving credit facility from CEO James E. Besser (Manchester Explorer, L.P.).","12% interest; maturity March 25, 2026; secured by all assets and intellectual property.","No borrowings as of filing date; accelerated repayment if company receives >$2M equity proceeds.","Draw amounts minimum $50K; maximum $350K less outstanding; optional prepayment without penalty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101028,"accession_number":"0001213900-26-007296","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2026-01-23T23:59:59+00:00","items":["3.03","5.03","5.07","9.01"],"status":"ready","headline":"Modular Medical shareholders approve 150% increase in authorized shares and reverse stock split authorization","event_type":"other_material","confidence":"high","bullets":["Authorized common shares increased from 100M to 250M (Proposal 3: 46.75M for, 5.04M against).","Board authorized to effect a reverse stock split at a ratio within a specified range within one year (Proposal 2: 50.6M for).","Equity incentive plan increased by 3M shares (Proposal 4: 35.38M for).","All eight director nominees elected, including CEO James Besser (not a candidate) and Duane DeSisto, Paul DiPerna, Steven Felsher, etc.","Farber Hass Hurley LLP ratified as independent auditor for fiscal year ending March 31, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117368,"accession_number":"0001213900-25-126825","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-12-31T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"Modular Medical gets 180-day Nasdaq extension to June 29, 2026 to meet $1 bid price","event_type":"regulatory","confidence":"high","bullets":["Nasdaq granted 180-day extension under Rule 5810(c)(3)(A) after initial non-compliance notice on June 30, 2025.","Company must close at $1.00 or more for 10 consecutive business days by June 29, 2026 to regain compliance.","If compliance not met by deadline, Nasdaq will issue delisting notice; company may appeal to hearings panel.","Trading continues on Nasdaq Capital Market under MODD with no immediate effect from extension.","Company will monitor bid price and evaluate options to regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117367,"accession_number":"0001213900-25-120759","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-12-11T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Modular Medical raises $4.68M in underwritten public offering of stock and warrants","event_type":"other_material","confidence":"high","bullets":["Offered 12,173,000 shares of common stock and warrants for 6,086,500 shares at combined price of $0.77 per unit.","Effective price of $0.38 per share and $0.01 per warrant; warrants exercisable at $0.45, expire in 5 years.","Gross proceeds of $4.68M; net proceeds to fund operations, working capital, and general corporate purposes.","Underwriter Newbridge Securities granted 30-day over-allotment option for up to 15% additional shares/warrants.","Directors and executive officers subject to 60-day lock-up; company subject to 90-day lock-up."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133794,"accession_number":"0001213900-25-090336","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-09-23T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Modular Medical induces warrant exercise for ~$3.7M gross; issues new warrants at premium","event_type":"other_material","confidence":"high","bullets":["Warrant holders exercise ~5.5M shares at $0.68/share (10% discount to NOCP), raising $3.7M.","Company issues ~2.75M new warrants (50% of exercised shares) with 5-year term at $0.84/share exercise price.","Newbridge Securities receives $400K fixed fee plus up to $50K expense reimbursement as servicing agent.","New warrants are unregistered and rely on Sections 3(a)(9) and 4(a)(2) exemptions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133793,"accession_number":"0001213900-25-061072","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Modular Medical receives Nasdaq minimum bid price deficiency notice; 180-day cure period","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Company of bid price deficiency: closing bid below $1.00 for 30 consecutive business days ending June 27, 2025.","Company has 180 calendar days (until Dec 29, 2025) to regain compliance by achieving $1.00 close for ten consecutive business days.","If not compliant by deadline, Company may request second 180-day period with reverse stock split if eligible.","No immediate delisting; Company is evaluating options to address the deficiency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150524,"accession_number":"0001213900-25-048276","cik":1074871,"company_name":"Modular Medical, Inc.","ticker":"MODD","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Modular Medical appoints Jeff Goldberg, insulin delivery veteran, to Board","event_type":"leadership","confidence":"high","bullets":["Appointed Jeff Goldberg to Board effective May 22, 2025.","Goldberg currently chairs Lannett Company, a generic pharma manufacturer that has launched generic insulin.","Previously served as President/CEO at IncuMed, Alfred E. Mann's incubator, overseeing insulin patch-pump program.","Also serves on boards of ATI Physical Therapy, Cano Health, and Eating Recovery Centers.","CEO Jeb Besser cited Goldberg's unique background at intersection of affordable drug-device combinations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}